Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Icade Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Nicolas Joly

İcra Kurulu Başkanı

€728.0k

Toplam tazminat

CEO maaş yüzdesi	42.7%
CEO görev süresi	1.5yrs
CEO sahipliği	n/a
Yönetim ortalama görev süresi	1.8yrs
Yönetim Kurulu ortalama görev süresi	5.3yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Nicolas Joly'un ücretlendirmesi Icade'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	-€953m
Mar 31 2024	n/a	n/a	-€1b
Dec 31 2023	€728k	€311k	-€1b

Tazminat ve Piyasa: Nicolas 'nin toplam tazminatı ($USD 805.81K ), French pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 1.54M ).

Tazminat ve Kazançlar: Nicolas şirketinin tazminatını şirket performansıyla karşılaştırmak için yeterli veri yok.

CEO

Nicolas Joly (41 yo)

1.5yrs

Görev süresi

€727,972

Tazminat

Mr. Nicolas Joly has been Chief Executive Officer of Icade since April 21, 2023. Mr. Joly served as Deputy Director-General at Mercialys and had been its Executive Vice-President since 2016. Mr. Joly joine...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Nicolas Joly	Chief Executive Officer	1.5yrs	€727.97k	Veri yok
Christelle De Robillard	Chief Financial Officer	less than a year	Veri yok	Veri yok
Sophie Duval	Head of Consolidation & Accounting	no data	Veri yok	Veri yok
Anne-Violette Faugeras	Director of Financing & Investor Relations	1.8yrs	Veri yok	Veri yok
Jérôme Lucchini	General Secretary and Head of Governance	9yrs	Veri yok	Veri yok
Emmanuelle Baboulin	Head of the Commercial Property Investment Division	9.1yrs	Veri yok	Veri yok
Xavier de La Sudrie	Head of Financial Control	no data	Veri yok	Veri yok
Johannah Mrejen	Head of Asset Management	no data	Veri yok	Veri yok
Guillaume Tessler	Head of International Development - Icade Santé	no data	Veri yok	Veri yok
Henri Chapouthier	Head of Sustainable Development	no data	Veri yok	Veri yok
Cathy Baglin	Head of Employee Affairs	no data	Veri yok	Veri yok
Benjamin Ficquet	Head of Property Management & Responsible Operations	no data	Veri yok	Veri yok

1.8yrs

Ortalama Görev Süresi

49yo

Ortalama Yaş

Deneyimli Yönetim: ICAD 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.8 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Bernard Spitz	Director	4yrs	€33.25k	0% € 0
Gonzague de Pirey	Independent Director	5.5yrs	€28.00k	0.00011% € 2.2k
Frederic Thomas	Chairman of the Board	8.4yrs	€240.00k	0.000040% € 799.6
Olivier Mareuse	Director	13.4yrs	Veri yok	0% € 0
Marianne Louradour	Director	5yrs	Veri yok	0% € 0
Antoine Saintoyant	Director	4yrs	Veri yok	0% € 0
Sophie Quatrehomme	Director	6.6yrs	Veri yok	0% € 0
Florence Peronnau	Vice Chairman of the Board & Lead Independent Director	8.4yrs	€101.25k	0.000010% € 199.9
Alexandre Thorel	Director	2.6yrs	Veri yok	Veri yok
Olivier Lecomte	Independent Director	less than a year	Veri yok	0.000010% € 199.9
Emmanuel Chabas	Director	5.5yrs	Veri yok	0% € 0
Laurence Giraudon	Director	4.7yrs	Veri yok	0% € 0

5.3yrs

Ortalama Görev Süresi

56.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ICAD 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.3 yıldır).

Icade Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Icade, Annual General Meeting, Apr 19, 2024

Recent updates

Price target increased by 7.4% to €30.32

First half 2024 earnings released: €2.38 loss per share (vs €6.80 loss in 1H 2023)

Now 23% undervalued after recent price drop

Now 21% undervalued

Now 20% undervalued

Price target decreased by 7.8% to €29.59

Price target decreased by 8.3% to €32.09

Price target decreased by 7.9% to €32.82

Dividend of €2.42 announced

Now 21% undervalued after recent price drop

Upcoming dividend of €2.42 per share

Icade, Annual General Meeting, Apr 19, 2024

Consensus EPS estimates upgraded to €6.67 loss, revenue downgraded

Consensus EPS estimates fall by 69%

Consensus EPS estimates fall by 63%

Icade to Report Q1, 2024 Results on Apr 22, 2024

Icade to Report First Half, 2024 Results on Jul 22, 2024

Icade to Report Fiscal Year 2023 Results on Feb 19, 2024

Icade(ENXTPA:ICAD) dropped from FTSE All-World Index (USD)

Price target decreased by 7.3% to €41.55

Consensus EPS estimates fall by 160%

Now 20% undervalued after recent price drop

Primonial REIM and Société Générale Assurances completed the acquisition of 63% stake in Icade Santé SAS from Icade (ENXTPA:ICAD) and its Minority Shareholders.

Upcoming dividend of €2.17 per share at 12% yield

Consensus estimates of losses per share improve by 75%

Vauban Infrastructure Partners and Icade (ENXTPA:ICAD) agreed to acquire A2A Coriance SAS.

Consensus EPS estimates fall by 17%, revenue upgraded

Oteis France Sas agreed to acquire AMO and EXPERTISE SANTE activity from Icade (ENXTPA:ICAD).

Consensus EPS estimates fall by 17%

Consensus estimates of losses per share improve by 16%

Consensus EPS estimates fall by 15%

An undisclosed buyer acquired Michigan Garden Project from Icade SA (ENXTPA:ICAD) for €108 million.

Icade SA (ENXTPA:ICAD) acquired Défense Parc complex in Nanterre Préfecture for €63 million.

Icade SA to Report Q1, 2023 Results on Apr 24, 2023

Icade SA to Report Fiscal Year 2022 Results on Feb 20, 2023

Consensus forecasts updated

Consensus forecasts updated

Elysées Pierre signed a bilateral preliminary agreement to acquire 16,000-Sq.m AXE 13 Office Building in Nanterre from Icade (ENXTPA:ICAD).

Investor sentiment deteriorated over the past week

Upcoming dividend of €2.10 per share

Funds managed by Primonial REIM acquired Gambetta building in paris from Icade (ENXTPA:ICAD) for approximately €220 million.

Funds managed by Primonial REIM acquired Gambetta building in paris from Icade (ENXTPA:ICAD) for approximately €220 million.

Residences Le Logement Des Fonctionnaires SA signed a bilateral preliminary agreement to acquire Residual Residential Portfolio from Icade (ENXTPA:ICAD) for €49.9 million.

Icade (ENXTPA:ICAD) acquired 50.1% interest in M&A Group.

Consensus forecasts updated

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Consensus forecasts updated

An unknown buyer completed the acquisition of Office building in Boulogne-Billancourt from Icade SA (ENXTPA:ICAD).

Consensus EPS estimates increase to €1.91

Consensus EPS estimates increase to €1.10

First half 2021 earnings released: EPS €2.52 (vs €0.07 in 1H 2020)

Consensus forecasts updated

Revenue beats expectations, earnings disappoint

A Look At Icade's (EPA:ICAD) Share Price Returns

New 90-day low: €55.50

Analysts update estimates

How Did Icade SA's (EPA:ICAD) 8.0% ROE Fare Against The Industry?

A pan-European fund dedicated to a German institutional investor managed by Aberdeen Standard Investments Limited acquired Two residential buildings in Rueil-Malmaison from Icade SA (ENXTPA:ICAD) for €14.6 million.

Icade SA (ENXTPA:ICAD) acquired Ad Vitam

Icade SA to Report Q1, 2021 Results on Apr 23, 2021

Icade SA (ENXTPA:ICAD) agreed to acquire Four Nursing Homes in France from Korian (ENXTPA:KORI) for €33.5 million.

What Type Of Shareholders Make Up Icade SA's (EPA:ICAD) Share Registry?

New 90-day high: €68.20

Market bids up stock over the past week

New 90-day low: €42.96

New 90-day low: €48.00

Analysts lower EPS estimates to €1.11

New 90-day low - €54.25

OPPCI owned by South Korean Investors completed the acquisition of 49% stake in Eqho Tower from Icade (ENXTPA:ICAD).

Icade (ENXTPA:ICAD) completed the acquisition of Pointe Métro 1 in Gennevilliers from Fonciere NW 2 Sppicav managed by NORMANDIE REIM.

New 90-day low - €55.45

Icade SA (ENXTPA : ICAD) agreed to acquire Portfolio of 9 Healthcare Facilities in Germany & France from Orpea SA (ENXTPA : ORP) for €145 million.

CEO Tazminat Analizi